Trademarkia Logo

Canada

C$
REATA PHARMACEUTICALS
REGISTERED

on 18 Sept 2019

Last Applicant/ Owned by

REATA PHARMACEUTICALS INC.

2801 Gateway Drive, Suite 150Irving, TX 75063

US

Serial Number

1775691 filed on 5th Apr 2016

Registration Number

TMA1055170 registered on 18th Sept 2019

Registration expiry Date

18th Sept 2029

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

CA

H3B1R1

REATA PHARMACEUTICALS

Trademark usage description

pharmaceutical preparations for the prevention and treatment of neurological disorders and degenerative nerve disorders, namely, alzheimer's disease, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of neurological disorders and degenerative nerve disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, demyelinating nerve disease, ALS and epilepsy; pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the prevention and treatment of the cardio-vascular system; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity, hypothyroidism and mitochondrial disease; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the immune system, namely, herpes, hepatitis, HIV infections, Acquired Immune Deficiency Syndrome (AIDS), and autoimmune diseases; pharmaceutical preparations for the treatment and prevention of acute or chronic kidney disease; pharmaceutical preparations for the prevention and treatment of skin diseases and disorders, namely, fibrotic skin disease and inflammatory skin disorders.


Classification kind code

11

Mark Details


Serial Number

1775691

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 51
on 6th Apr 2018
Allowance Notice Sent
Submitted for opposition 50
on 6th Apr 2018
Allowed
Submitted for opposition 42
on 20th Dec 2017
Advertised
Submitted for opposition 26
on 30th Nov 2017
Approved
Submitted for opposition 27
on 10th Oct 2017
Approval Notice Sent
Submitted for opposition 22
on 9th Jan 2017
Search Recorded
Submitted for opposition 20
on 9th Jan 2017
Examiner's First Report
Submitted for opposition 31
on 12th Apr 2016
Formalized
Submitted for opposition 1
on 6th Apr 2016
Created
Submitted for opposition 30
on 5th Apr 2016
Filed